Citations

Clear

815 citation(s) found for "Tang, Yu".

Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions
Adams, Diane K. , Alpaugh, R. Katherine , Cristofanilli, Massimo , Martin, Stuart S. , Chumsri, Saranya , Tang, Cha-Mei, Marks, Jeffrey R. , Adams, Daniel L. , Tang, Cha‐Mei , Cristofanilli, Massimo

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | May 17, 2016 | Volume: 25 | Issue: 7 | Pages: 1037-1042

10.1158/1055-9965.epi-15-1221 | PMID 27197300 Get It

Abstract Background: Blood-based testing can be used as a noninvasive method to recover and analyze circulating tumor-derived cells for clinical use. Circulating cancer-associated macrophage-like cells (CAML) are specialized myeloid cells found in peripheral blood and associated with the presence of solid malignancies. We measured CAMLs prospectively in peripheral blood to ascertain their prevalence, specificity, and sensitivity in relation to breast disease status at clinical presentation. Methods: We report on two related but separate studies: 1) CellSieve microfilters were used to isolate CAMLs from blood samples of patients with known malignant disease (n = 41). Prevalence and specificity was compared against healthy volunteers (n = 16). 2) A follow-up double-blind pilot study was conducted on women (n = 41) undergoing core-needle biopsy to diagnose suspicious breast masses. Results: CAMLs were found in 93% of known malignant patients (n = 38/41), averaging 19.4 cells per sample, but none in the healthy controls. In subjects undergoing core biopsy for initial diagnosis, CAMLs were found in 88% of subjects with invasive carcinoma (n = 15/17) and 26% with benign breast conditions (n = 5/19). Conclusion: These preliminary pilot studies suggest that the presence of CAMLs may differentiate patients with malignant disease, benign breast conditions, and healthy individuals. Impact: We supply evidence that this previously unidentified circulating stromal cell may have utility as a screening tool to detect breast cancer in various malignancies, irrespective of disease stage. Cancer Epidemiol Biomarkers Prev; 25(7); 1037–42. ©2016 AACR.
Functional and transport analyses of CLCN5 genetic changes identified in Dent disease patients
Tang, Xiaojing , Brown, Matthew , Cogal, Andrea G. , Gauvin, Daniel, Harris, Peter C. , Romero, Michael F. , Chang, Min‐Hwang , Lieske, John C. , Harris, Peter C , Brown, Matthew R , Romero, Michael F

Mayo Clinic

Physiological Reports | April 26, 2016 | Volume: 4 | Issue: 8 | Pages: e12776

10.14814/phy2.12776 | PMID 27117801 Get It

Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration
Monette, Jeffrey S., Hutchins, Patrick M., Ronsein, Graziella E. , Wimberger, Jake , Irwin, Angela D. , Tang, Chongren, Sara, Jaskanwal Deep Singh , Vaisar, Tomáš , Heinecke, Jay W. , Sara, Jaskanwal D, Shao, Baohai, Shao, Baohai , Lerman, Amir

Mayo Clinic

Circulation Research | April 26, 2016 | Volume: 119 | Issue: 1 | Pages: 83-90

10.1161/circresaha.116.308357 | PMID 27114438 Get It

Rationale: Coronary endothelial dysfunction (ED)—an early marker of atherosclerosis—increases the risk of cardiovascular events. Objective: We tested the hypothesis that cholesterol efflux capacity and high-density lipoprotein (HDL) particle concentration predict coronary ED better than HDL-cholesterol (HDL-C). Methods and Results: We studied 80 subjects with nonobstructive (<30% stenosis) coronary artery disease. ED was defined as <50% change in coronary blood flow in response to intracoronary infusions of acetylcholine during diagnostic coronary angiography. Cholesterol efflux capacity and HDL particle concentration (HDL-P IMA ) were assessed with validated assays. Cholesterol efflux capacity and HDL-P IMA were both strong, inverse predictors of ED ( P <0.001 and 0.005, respectively). In contrast, HDL-C and other traditional lipid risk factors did not differ significantly between control and ED subjects. Large HDL particles were markedly decreased in ED subjects (33%; P =0.005). After correction for HDL-C, both efflux capacity and HDL-P IMA remained significant predictors of ED status. HDL-P IMA explained cholesterol efflux capacity more effectively than HDL-C ( r =0.54 and 0.36, respectively). The efflux capacities of isolated HDL and serum HDL correlated strongly ( r =0.49). Conclusions: Cholesterol efflux capacity and HDL-P IMA are reduced in subjects with coronary ED, independently of HDL-C. Alterations in HDL-P IMA and HDL itself account for a much larger fraction of the variation in cholesterol efflux capacity than does HDL-C. A selective decrease in large HDL particles may contribute to impaired cholesterol efflux capacity in ED subjects. These observations support a role for HDL size, concentration, and function as markers—and perhaps mediators—of coronary atherosclerosis in humans.
Circulating cellular adhesion molecules and risk of diabetes: the Multi‐Ethnic Study of Atherosclerosis (MESA)
Pankow, James S. , Decker, Paul A. , Berardi, Cecilia , Hanson, Naomi Q., Sale, Michèle M. , Tang, Weihong , Tsai, Michael Y. , Wassel, Christina L. , Bielinski, Suzette J. , Decker, Paul A. , Kanaya, Alka M , Larson, Nicholas B. , Bielinski, Suzette , Pankow, James S , Tang, Weihong

Mayo Clinic

Diabetic Medicine | March 3, 2016 | Volume: 33 | Issue: 7 | Pages: 985-991

10.1111/dme.13108 | PMID 26937608 Get It

AbstractAimsTo test the hypothesis that soluble cellular adhesion molecules would be positively and independently associated with risk of diabetes.MethodsSoluble levels of six cellular adhesion molecules (ICAM‐1, E‐selectin, VCAM‐1, E‐cadherin, L‐selectin and P‐selectin) were measured in participants in the Multi‐Ethnic Study of Atherosclerosis, a prospective cohort study. Participants were then followed for up to 10 years to ascertain incident diabetes.ResultsSample sizes ranged from 826 to 2185. After adjusting for age, sex, race/ethnicity, BMI and fasting glucose or HbA1c, four cellular adhesion molecules (ICAM‐1, E‐selectin, VCAM‐1 and E‐cadherin) were positively associated with incident diabetes and there was a statistically significant trend across quartiles. Comparing the incidence of diabetes in the highest and lowest quartiles of each cellular adhesion molecule, the magnitude of association was largest for E‐selectin (hazard ratio 2.49; 95% CI 1.26–4.93) and ICAM‐1 (hazard ratio 1.76; 95% CI 1.22–2.55) in fully adjusted models. Tests of effect modification by racial/ethnic group and sex were not statistically significant for any of the cellular adhesion molecules (P > 0.05).ConclusionsThe finding of significant associations between multiple cellular adhesion molecules and incident diabetes may lend further support to the hypothesis that microvascular endothelial dysfunction contributes to risk of diabetes.
Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial
Petrylak, Daniel P. , Tagawa, Scott T. , Eisen, Andrea , Canil, Christina , Burke, John M. , Shaffer, David R. , Pan, Chong‐Xian, Aragon‐Ching, Jeanny B. , Tang, Shande, Zhang, Hui , Cavanaugh, Christopher , Gao, Ling , Walgren, Richard A., Kohli, Manish , Spira, Alexander, Yu, Evan Y., Shaffer, David, Kim, Jenny J, Aragon-Ching, Jeanny B, Quinn, David I, Vogelzang, Nicholas J. , Cavanaugh, Christopher T, Kauh, John S, Chi, Kim N, Sridhar, Srikala S , Spira, Alexander I. , Yu, Evan Y , Kim, Jaeyeon , Quinn, David I , Kauh, John Sae Wook , N., Kim , Tagawa, Scott T , Eisen, Andrea

Mayo Clinic

Journal of Clinical Oncology | March 1, 2016 | Volume: 34 | Issue: 13 | Pages: 1500-1509

10.1200/jco.2015.65.0218 | PMID 26926681 Get It

Purpose This trial assessed the efficacy and safety of docetaxel monotherapy or docetaxel in combination with ramucirumab (vascular endothelial growth factor receptor 2 antibody) or icrucumab (vascular endothelial growth factor receptor 1 antibody) after progression during or within 12 months of platinum-based regimens for patients with locally advanced or metastatic urothelial carcinoma. Patients and Methods Patients were randomly assigned (1:1:1) to receive docetaxel 75 mg/m2 intravenously (IV) on day 1 of a 3-week cycle (arm A), docetaxel 75 mg/m2 IV plus ramucirumab 10 mg/kg IV on day 1 of a 3-week cycle (arm B), or docetaxel 75 mg/m2 IV on day 1 plus icrucumab 12 mg/kg IV on days 1 and 8 of a 3-week cycle (arm C). Treatment continued until disease progression or unacceptable toxicity. The primary end point was investigator-assessed progression-free survival (PFS). Results A total of 140 patients were randomly assigned and treated in arms A (n = 45), B (n = 46), or C (n = 49). PFS was significantly longer in arm B compared with arm A (median, 5.4 months; 95% CI, 3.1 to 6.9 months v 2.8 months; 95% CI, 1.9 to 3.6 months; stratified hazard ratio, 0.389; 95% CI, 0.235 to 0.643; P = .0002). Arm C did not experience improved PFS compared with arm A (1.6 months; 95% CI, 1.4 to 2.9; stratified hazard ratio, 0.863; 95% CI, 0.550 to 1.357; P = .5053). The most common grade 3 or worse adverse events (arms A, B, and C) were neutropenia (36%, 33%, and 39%), fatigue (13%, 30%, and 20%), febrile neutropenia (13%, 17%, and 6.1%), and anemia (6.7%, 13%, and 14%, respectively). Conclusion The addition of ramucirumab to docetaxel met the prespecified efficacy end point for prolonging PFS in patients with locally advanced or metastatic urothelial carcinoma receiving second-line treatment and warrants further investigation in the phase III setting.
The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice
Zhang, Zubin , Tong, Jiefei , Tang, Xiaowen , Juan, Jiaxiang , Cao, Biyin, Hurren, Rose, Chen, Guodong , Taylor, Paul , Xu, Xin , Shi, Chang-Xin, Hou, Jian , Wang, Guanghui , Stewart, A. Keith, Schimmer, Aaron D. , Mao, Xinliang , Chen, Guodong, Du, Juan , Wu, Depei , Moran, Michael F.

Mayo Clinic

Blood | January 30, 2016 | Volume: 127 | Issue: 13 | Pages: 1676-1686

10.1182/blood-2015-07-658203 | PMID 26825710 Get It

Key Points HERC4 is the first identified ubiquitin ligase that mediates c-Maf ubiquitination and degradation. HERC4 suppresses MM cell proliferation and delays MM tumor growth.
Precision microfilters as an all in one system for multiplex analysis of circulating tumor cells
Alpaugh, R. Katherine , Martin, Stuart S. , Charpentier, Monica S., Chumsri, Saranya , Cristofanilli, Massimo , Adams, Diane K. , Zhu, Peixuan , Li, Shuhong , Tang, Cha‐Mei , Adams, Daniel L. , Makarova, Olga V. , Stefansson, Steingrimur , Cristofanilli, Massimo

Mayo Clinic

RSC Advances | January 11, 2016 | Volume: 6 | Issue: 8 | Pages: 6405-6414

10.1039/c5ra21524b | PMID 29093811 Get It

An all-in-one Circulating Tumor Cell (CTC) isolation platform with streamlined multiplex integration of proteomic and genomic clinical testing.
O2‐01‐03: Amyloid load increase and cerebral microbleed prevalence differ as a function of the position of the mutation within the PSEN1 coding sequence
Tang, Mengxuan , Owen, Christopher J. , Su, Yi , Hornbeck, Russ C. , Stevenson, Trish A., Cash, Lisa, Raichle, Marcus E., Preboske, Gregory M., Xiong, Chengjie , Moulder, Krista L., Buckles, Virginia, Joseph‐Mathurin, Nelly , Friedrichsen, Karl A. , Raichle, Marcus E. , Gordon, Brian A. , Koeppe, Robert A. , Jack, Clifford R. , Goate, Alison , Cruchaga, Carlos , Bateman, Randall J. , Morris, John C. , Benzinger, Tammie L.S.

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_4 | Pages: No page available

10.1016/j.jalz.2015.07.132 Get It

IC‐P‐051: Amyloid load increase and cerebral microbleed prevalence differ as a function of the position of the mutation within the PSEN1 coding sequence
Tang, Mengxuan , Owen, Christopher J. , Hornbeck, Russ C. , Stevenson, Trish A., Cash, Lisa, Raichle, Marcus E. , Preboske, Gregory M., Xiong, Chengjie , Moulder, Krista L., Buckles, Virginia, Joseph‐Mathurin, Nelly , Friedrichsen, Karl A. , Su, Yi , Gordon, Brian A. , Koeppe, Robert A. , Jack, Clifford R. , Goate, Alison , Cruchaga, Carlos , Bateman, Randall J. , Morris, John C. , Benzinger, Tammie L.S.

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_1 | Pages: No page available

10.1016/j.jalz.2015.06.072 Get It

Impact of adiposity on cellular adhesion: The Multi‐Ethnic Study of atherosclerosis (MESA)
Christoph, Mary J. , Allison, Matthew , Pankow, James S. , Decker, Paul A. , Kirsch, Phillip S., Tsai, Michael Y. , Sale, Michèle M. , Sicotte, Hugues , Tang, Weihong , Hanson, Naomi Q., Berardi, Cecilia , Wassel, Christina L. , Bielinski, Suzette J. , de Andrade, Mariza, Decker, Paul A. , Andrade, Mariza de , Larson, Nicholas B. , Bielinski, Suzette , Pankow, James S , Tang, Weihong , Allison, Matthew A

Mayo Clinic

Obesity | December 6, 2015 | Volume: 24 | Issue: 1 | Pages: 223-230

10.1002/oby.21245 | PMID 26638193 Get It

ObjectiveAt the cellular level, how excess adiposity promotes atherogenesis is not fully understood. One pathway involves secretion of adipokines that stimulate endothelial dysfunction through increased expression of adhesion molecules. However, the relationship of adiposity to adhesion molecules that promote atherosclerosis is largely unknown.MethodsLinear regression models were used to assess the sex‐specific associations of soluble cellular adhesion molecules (sP‐ and sL‐selectin, sICAM‐1, sVCAM‐1, and sHGF) and adiposity in 5,974 adults examined as part of the Multi‐Ethnic Study of Atherosclerosis (MESA). Adiposity measures included body mass index (BMI), waist‐to‐hip‐ratio (WHR), and computed tomography measures of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT).ResultsThe mean age was 64 years and 52% were female. In multivariable models adjusting for traditional cardiovascular risk factors, sHGF was positively associated with BMI, WHR, and VAT in both males and females, and sP‐selectin with WHR and VAT in males. sVCAM‐1 was inversely associated with VAT in females only.ConclusionsOur results showed the relation of adiposity to soluble cellular adhesion proteins was similar across adiposity measures and for both sexes. However, the relationship between adiposity and sVCAM‐1 and P‐selectin may be modified by sex and the measure used to assess adiposity.